Needham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) Director Gotham Makker sold 274,000 shares of the company’s stock in a transaction that occurred on Thursday, March 21st. The stock was sold at an average price of $28.43, for a total value of $7,789,820.00. Following the transaction, the director now directly owns 365,912 shares of the […]
Rocket Pharmaceuticals (NASDAQ:RCKT – Get Free Report)‘s stock had its “overweight” rating restated by investment analysts at Cantor Fitzgerald in a research note issued to investors on Tuesday, Benzinga reports. They currently have a $65.00 target price on the biotechnology company’s stock. Cantor Fitzgerald’s price objective suggests a potential upside of 118.93% from the stock’s […]
Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) have received a consensus recommendation of “Buy” from the nine brokerages that are presently covering the stock, Marketbeat.com reports. Nine equities research analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have issued ratings on the […]
Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Get Free Report) has been assigned a consensus rating of “Buy” from the nine ratings firms that are presently covering the stock, Marketbeat Ratings reports. Nine equities research analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued a report on […]